Specialty Overview

Best Hospitals for Alpha-1-Antitrypsin Deficiency in Bengaluru, India

10 liver transplant & hpb hospitals in our India network are listed in Bengaluru, accredited by NABH, JCI, NABL, ISO 9001, with 3,630 beds combined.

10
Hospitals Listed
1
City
4.5
Avg. Rating
4
Accreditation Types
The Short Answer

This page lists the liver transplant & hpb hospitals in our directory offering Alpha-1-Antitrypsin Deficiency in Bengaluru, India, including Narayana Health, Manipal Hospitals, Medicover Hospital, Bangalore, Gleneagles Hospitals, Bengaluru and others. Each listing links through to the hospital's full profile page.

Ask us about alpha-1-antitrypsin deficiency in Bengaluru, India

Share a few details and our care coordination team will get back to you with next steps.

Top Hospitals for Alpha-1-Antitrypsin Deficiency in Bengaluru, India

🇮🇳 Narayana Health

Bengaluru, India 4.8 (1750 reviews) 1,000 beds
Why consider this hospital?
4.8/5 rating from 1750 reviews1,000 beds
Specialties & Accreditation
CardiacPediatric SurgeryCancer
NABHNational Accreditation Board for Hospitals & Healthcare Providers accreditation

Patients considering alpha-1-antitrypsin deficiency can be cared for by Narayana Health's care team in Bengaluru, India, from initial consultation through recovery. Narayana Health, accredited by NABH, follows recognised patient-safety and quality-of-care standards when performing alpha-1-antitrypsin deficiency.

4.8/5
Rating
2000
Established
1,000
Beds
Bengaluru, India
Location
Manipal Hospitals

🇮🇳 Manipal Hospitals

Bengaluru, India 4.7 (1450 reviews) 600 beds
Why consider this hospital?
4.7/5 rating from 1450 reviews600 beds
Specialties & Accreditation
OrthopedicsNeurologyIVF
JCIJoint Commission International accreditationNABHNational Accreditation Board for Hospitals & Healthcare Providers accreditation

Patients considering alpha-1-antitrypsin deficiency can be cared for by Manipal Hospitals's care team in Bengaluru, India, from initial consultation through recovery. Manipal Hospitals, accredited by JCI, NABH, follows recognised patient-safety and quality-of-care standards when performing alpha-1-antitrypsin deficiency.

4.7/5
Rating
1991
Established
600
Beds
Bengaluru, India
Location
Medicover Hospital, Bangalore

🇮🇳 Medicover Hospital, Bangalore

Bengaluru, India 4.7 (68 reviews) 300 beds
Why consider this hospital?
4.7/5 rating from 68 reviews300 beds
Specialties & Accreditation
Cardiac SurgeryCardiologyOncologyNeurologyOrthopedicsUrology
NABHNational Accreditation Board for Hospitals & Healthcare Providers accreditation

Patients considering alpha-1-antitrypsin deficiency can be cared for by Medicover Hospital, Bangalore's care team in Bengaluru, India, from initial consultation through recovery. Medicover Hospital, Bangalore, accredited by NABH, follows recognised patient-safety and quality-of-care standards when performing alpha-1-antitrypsin deficiency.

4.7/5
Rating
2024
Established
300
Beds
Bengaluru, India
Location
Gleneagles Hospitals, Bengaluru

🇮🇳 Gleneagles Hospitals, Bengaluru

Bengaluru, India 4.7 (142 reviews) 40 beds
Why consider this hospital?
4.7/5 rating from 142 reviews40 beds
Specialties & Accreditation
Cardiac SurgeryCardiologyOncologyNeurologyOrthopedicsGastroenterology
NABHNational Accreditation Board for Hospitals & Healthcare Providers accreditation

Patients considering alpha-1-antitrypsin deficiency can be cared for by Gleneagles Hospitals, Bengaluru's care team in Bengaluru, India, from initial consultation through recovery. Gleneagles Hospitals, Bengaluru, accredited by NABH, follows recognised patient-safety and quality-of-care standards when performing alpha-1-antitrypsin deficiency.

4.7/5
Rating
2017
Established
40
Beds
Bengaluru, India
Location
Manipal Hospital Malleshwaram (Northside)

🇮🇳 Manipal Hospital Malleshwaram (Northside)

Malleshwaram, Bengaluru, India 4.6 (71 reviews) 83 beds
Why consider this hospital?
4.6/5 rating from 71 reviews83 beds
Specialties & Accreditation
Cardiac SciencesOrthopedicsNeurosciencesGastroenterologyOncology
NABHNational Accreditation Board for Hospitals & Healthcare Providers accreditationNABLNational Accreditation Board for Testing and Calibration Laboratories accreditationISOISO 9001 certification

Patients considering alpha-1-antitrypsin deficiency can be cared for by Manipal Hospital Malleshwaram (Northside)'s care team in Malleshwaram, Bengaluru, India, from initial consultation through recovery. Manipal Hospital Malleshwaram (Northside), accredited by NABH, NABL, ISO 9001, follows recognised patient-safety and quality-of-care standards when performing alpha-1-antitrypsin deficiency.

4.6/5
Rating
1993
Established
83
Beds
Malleshwaram, Bengaluru, India
Location
Manipal Hospital, Old Airport Road

🇮🇳 Manipal Hospital, Old Airport Road

Bangalore, India 4.5 (87 reviews) 680 beds
Why consider this hospital?
4.5/5 rating from 87 reviews680 beds
Specialties & Accreditation
Cardiac SurgeryNeurosciencesTransplantOncologyOrthopedics
NABHNational Accreditation Board for Hospitals & Healthcare Providers accreditationJCIJoint Commission International accreditation

Patients considering alpha-1-antitrypsin deficiency can be cared for by Manipal Hospital, Old Airport Road's care team in Bangalore, India, from initial consultation through recovery. Manipal Hospital, Old Airport Road, accredited by NABH, JCI, follows recognised patient-safety and quality-of-care standards when performing alpha-1-antitrypsin deficiency.

4.5/5
Rating
1991
Established
680
Beds
Bangalore, India
Location
Manipal Hospital Yeshwanthpur (Columbia Asia)

🇮🇳 Manipal Hospital Yeshwanthpur (Columbia Asia)

Yeshwanthpur, Bangalore, India 4.5 (98 reviews) 168 beds
Why consider this hospital?
4.5/5 rating from 98 reviews168 beds
Specialties & Accreditation
Cardiac SciencesOrthopedicsNeurosciencesOncologyGastroenterology
NABHNational Accreditation Board for Hospitals & Healthcare Providers accreditationJCIJoint Commission International accreditation

Patients considering alpha-1-antitrypsin deficiency can be cared for by Manipal Hospital Yeshwanthpur (Columbia Asia)'s care team in Yeshwanthpur, Bangalore, India, from initial consultation through recovery. Manipal Hospital Yeshwanthpur (Columbia Asia), accredited by NABH, JCI, follows recognised patient-safety and quality-of-care standards when performing alpha-1-antitrypsin deficiency.

4.5/5
Rating
2008
Established
168
Beds
Yeshwanthpur, Bangalore, India
Location
Manipal Hospital Millers Road (Vikram Hospital)

🇮🇳 Manipal Hospital Millers Road (Vikram Hospital)

Millers Road, Bangalore, India 4.4 (74 reviews) 225 beds
Why consider this hospital?
4.4/5 rating from 74 reviews225 beds
Specialties & Accreditation
Cardiac SciencesOrthopedicsNeurosciencesOncologyGastroenterology
NABHNational Accreditation Board for Hospitals & Healthcare Providers accreditation

Patients considering alpha-1-antitrypsin deficiency can be cared for by Manipal Hospital Millers Road (Vikram Hospital)'s care team in Millers Road, Bangalore, India, from initial consultation through recovery. Manipal Hospital Millers Road (Vikram Hospital), accredited by NABH, follows recognised patient-safety and quality-of-care standards when performing alpha-1-antitrypsin deficiency.

4.4/5
Rating
2009
Established
225
Beds
Millers Road, Bangalore, India
Location
Apollo Hospital, Bannerghatta Road

🇮🇳 Apollo Hospital, Bannerghatta Road

Bangalore, India 4.2 (25 reviews) 250 beds
Why consider this hospital?
4.2/5 rating from 25 reviews250 beds
Specialties & Accreditation
Cardiac SurgeryCardiologyMedical OncologyBreast SurgerySpine SurgeryBariatric Surgery
JCIJoint Commission International accreditationNABHNational Accreditation Board for Hospitals & Healthcare Providers accreditation

Patients considering alpha-1-antitrypsin deficiency can be cared for by Apollo Hospital, Bannerghatta Road's care team in Bangalore, India, from initial consultation through recovery. Apollo Hospital, Bannerghatta Road, accredited by JCI, NABH, follows recognised patient-safety and quality-of-care standards when performing alpha-1-antitrypsin deficiency.

4.2/5
Rating
2007
Established
250
Beds
Bangalore, India
Location
Fortis Hospital, Bannerghatta Road

🇮🇳 Fortis Hospital, Bannerghatta Road

Bangalore, India 4.2 (58 reviews) 284 beds
Why consider this hospital?
4.2/5 rating from 58 reviews284 beds
Specialties & Accreditation
Multi SpecialtyCardiac SurgeryNeurosciencesOrthopedicsCancer
NABHNational Accreditation Board for Hospitals & Healthcare Providers accreditationJCIJoint Commission International accreditation

Patients considering alpha-1-antitrypsin deficiency can be cared for by Fortis Hospital, Bannerghatta Road's care team in Bangalore, India, from initial consultation through recovery. Fortis Hospital, Bannerghatta Road, accredited by NABH, JCI, follows recognised patient-safety and quality-of-care standards when performing alpha-1-antitrypsin deficiency.

4.2/5
Rating
2006
Established
284
Beds
Bangalore, India
Location

Top Liver Transplant & HPB Doctors in Bengaluru, India

Image not available Featured

Dr. Chethan C M

MBBS, MS in General Surgery, MCh in HPB Surgery
Consultant — HPB and Liver Transplant Surgeon · Specialty: HPB and Liver Transplant Surgeon
Apollo Hospitals, Bannerghatta Road Bengaluru, India18+ Years experience
Why consider this doctor?
  • 18+ years of experience in HPB and Liver Transplant Surgeon
  • Consultant — HPB and Liver Transplant Surgeon, Apollo Hospitals, Bannerghatta Road, Bengaluru, India
  • Senior surgical practitioner with 18+ years of experience in hepato-pancreato-biliary and liver transplant surgery
Expertise & Procedures
  • Liver Resection and Hepatectomy
  • Deceased Donor Liver Transplantation
  • ABO-compatible and ABO-incompatible Liver Transplant
  • Whipple Procedure (Pancreaticoduodenectomy)
  • Distal Pancreatectomy
View all procedures →
HPB and Liver Transplant Surgeon Experience: 18+ YearsHospital Affiliation: Apollo Hospitals, Bannerghatta RoadHospital accreditation: JCI, NABH
Image not available

Dr. Mahesh Gopasetty

MBBS, MS, MRCS, Fellowship in Multi-Organ Transplantation, Fellowship in Paediatric Multivisceral Transplantation
HOD & Lead Consultant — Liver Transplant & HPB Surgery · Specialty: Hepato-Pancreato-Biliary Surgeon & Liver Transplant Specialist
Gleneagles Hospitals Bengaluru, India15+ Years experience
Why consider this doctor?
  • 15+ years of experience in Hepato-Pancreato-Biliary Surgeon & Liver Transplant Specialist
  • HOD & Lead Consultant – Liver Transplant & HPB Surgery, Gleneagles Hospitals, Bengaluru
  • Senior Consultant – Hepato-Pancreato-Biliary Surgery, Gleneagles BGS Hospital, Kengeri, Bengaluru
Expertise & Procedures
  • Liver transplantation (adult and pediatric)
  • Multivisceral transplantation
  • Whipple procedure (pancreaticoduodenectomy)
  • Distal pancreatectomy
  • Pancreas transplantation
View all procedures →
Hepato-Pancreato-Biliary Surgeon & Liver Transplant Specialist Experience: 15+ YearsHospital Affiliation: Gleneagles HospitalsHospital accreditation: NABH, JCI
Image not available

Dr. Pradeep Krishna R V

MS, MCh, Post-Doctoral Fellowship in HPB Surgery & Liver Transplantation
Senior Consultant — Surgical Gastroenterology, HPB & Transplant · Specialty: HPB & Transplant Surgeon
Apollo Hospitals, Bannerghatta Road Bengaluru, India16+ Years experience
Why consider this doctor?
  • 16+ years of experience in HPB & Transplant Surgeon
  • Senior Consultant, Department of HPB Surgery and Liver Transplantation, Apollo Hospitals, Bannerghatta Road, Bengaluru — Present
  • HPB & Transplant Surgeon, BGS Gleneagles Global Hospital, Bengaluru
Expertise & Procedures
  • Living donor liver transplantation
  • Deceased donor liver transplantation
  • Pediatric liver transplantation
  • Liver resection and hepatectomy
  • Whipple procedure (pancreaticoduodenectomy)
View all procedures →
HPB & Transplant Surgeon Experience: 16+ YearsHospital Affiliation: Apollo Hospitals, Bannerghatta RoadHospital accreditation: JCI, NABH
Image not available

Dr. Pramod Kumar D A

DM, MD
Senior Consultant — Hepatology & Liver Transplantation · Specialty: Hepatologist & Liver Transplant Specialist
Apollo Hospitals, Bannerghatta Road Bengaluru, India16+ Years experience
Why consider this doctor?
  • 16+ years of experience in Hepatologist & Liver Transplant Specialist
  • Senior Consultant — Hepatology & Liver Transplantation, Apollo Hospitals, Bannerghatta Road, Bengaluru — Present
  • Clinical expertise spanning 16+ years in comprehensive hepatology and liver transplant medicine
Expertise & Procedures
  • Liver Transplant Evaluation and Optimization
  • Liver Transplant Post-Operative Management
  • Advanced Liver Fibrosis Assessment
  • Endoscopic Variceal Ligation (EVL)
  • TIPS Procedure (Transjugular Intrahepatic Portosystemic Shunt)
View all procedures →
Hepatologist & Liver Transplant Specialist Experience: 16+ YearsHospital Affiliation: Apollo Hospitals, Bannerghatta RoadHospital accreditation: JCI, NABH
Image not available

Dr. Ravindra Nidoni

MBBS, MS (General Surgery), DNB (Surgical Gastroenterology), Fellowship in Liver Transplant & HPB Surgery, FACS
Consultant — Liver Transplant & HPB Surgeon · Specialty: Hepato-Pancreato-Biliary Surgeon
Gleneagles Hospitals Bengaluru, India10+ Years experience
Why consider this doctor?
  • 10+ years of experience in Hepato-Pancreato-Biliary Surgeon
  • Consultant, Hepato-Pancreato-Biliary and Liver Transplant Surgeon — Gleneagles Hospitals, Bengaluru — Present
  • Surgical expertise spanning liver transplantation, pancreatic surgery, and complex HPB procedures — 10+ years
Expertise & Procedures
  • Orthotopic liver transplantation from deceased and living donors
  • Partial hepatectomy and liver resection for cancer
  • Whipple procedure (pancreaticoduodenectomy)
  • Distal pancreatectomy with splenectomy
  • Pylorus-preserving pancreaticoduodenectomy
View all procedures →
Hepato-Pancreato-Biliary Surgeon Experience: 10+ YearsHospital Affiliation: Gleneagles HospitalsHospital accreditation: NABH, JCI
Image not available

Dr. Sanjay Govil

MBBS, MS (General Surgery), FRCS (Edinburgh), FRCS (Intercollegiate, UK) — Fellowship in Hepatobiliary & Transplant Surgery
Lead Consultant — Hepatobiliary and Transplant Surgery · Specialty: Hepatobiliary and Transplant Surgeon
Apollo Hospitals, Bannerghatta Road Bengaluru, India30+ Years experience
Why consider this doctor?
  • 30+ years of experience in Hepatobiliary and Transplant Surgeon
  • Lead Consultant — Hepatobiliary and Transplant Surgery, Apollo Hospitals, Bannerghatta Road, Bengaluru
  • Faculty, International Laparoscopy Fellowship Course Coordinator, Apollo Health Education and Research Foundation, Apollo Hospitals, Chennai
Expertise & Procedures
  • Liver transplantation (deceased and living donor)
  • Hepatic resection and partial hepatectomy
  • Whipple procedure (pancreaticoduodenectomy)
  • Distal pancreatectomy
  • Hepaticojejunostomy
View all procedures →
Hepatobiliary and Transplant Surgeon Experience: 30+ YearsHospital Affiliation: Apollo Hospitals, Bannerghatta RoadHospital accreditation: JCI, NABH
Our Methodology

How we selected these hospitals

A hospital appears on this page when Liver Transplant & HPB is among its listed specialties and it is located in Bengaluru, India. Hospitals are not ranked by a proprietary "best" score — the order follows the listed rating (highest first), the same field shown on each hospital's profile.

What To Look For

How to Select the Best Hospital for Alpha-1-Antitrypsin Deficiency in Bengaluru, India?

Choosing the right hospital for alpha-1-antitrypsin deficiency is one of the most important decisions in your treatment journey. A few factors are worth weighing before you decide:

International Accreditation

Look for a hospital with international accreditation such as JCI or NABH — see the accreditation badges shown for each hospital below.

Specialization

Check that the hospital's listed specialties actually include liver transplant & hpb rather than only general care.

Capacity and Track Record

Bed count and year established (shown below for each hospital) are a reasonable proxy for scale and operating experience.

Transparent Costs

Ask for an itemised, all-inclusive estimate — hospital charges, room category and stay — before you travel. Our cost calculator (linked below) gives a starting estimate.

Clinical Overview

Understanding Alpha-1-Antitrypsin Deficiency

Alpha-1-Antitrypsin Deficiency (AATD) is a serious inherited metabolic disorder that leads to progressive emphysema and liver disease; AAT augmentation therapy (intravenous infusion of purified human alpha-1-antitrypsin) is the only disease-modifying treatment proven to slow lung function decline in Pi*ZZ and related phenotypes, with clinical studies demonstrating a statistically significant reduction in CT-measured lung density loss and annual FEV1 decline.

1–2 days per infusion cycle (outpatient or short-stay); 5–10 days for initial diagnostic work-up and therapy induction if travelling internationally
Hospital Stay
1–2 weeks for initial evaluation, therapy initiation, and tolerance monitoring before international travel home; ongoing therapy requires return visits every 4–8 weeks or coordination with a home infusion provider
Total Stay in Country (Fit-to-Fly)
Augmentation therapy reduces annual CT lung density decline by approximately 34% compared to placebo (RAPID trial data); liver-directed therapies (RNA interference, gene therapy trials) show 80–95% target engagement in early-phase studies. Overall treatment response (stabilisation of lung function trajectory) is documented in 70–85% of compliant patients.
Success Rate

Clinical Overview

  • Alpha-1-Antitrypsin Deficiency (AATD) is an autosomal co-dominant genetic disorder caused by mutations in the SERPINA1 gene, most commonly the Pi*Z (Glu342Lys) allele.
  • The resulting misfolded AAT protein is retained within hepatic endoplasmic reticulum, reducing circulating AAT to less than 11 µmol/L — far below the protective threshold of 35 µmol/L needed to neutralise neutrophil elastase in alveolar tissue.
  • The unopposed elastase activity progressively destroys alveolar walls, producing panlobular emphysema with a characteristic basal predominance on high-resolution CT (HRCT).
Full details →

Who is a Candidate?

  • CONFIRMED PHENOTYPE: Pi*ZZ, Pi*ZNull, Pi*SZ, or other severe AATD genotypes confirmed by serum AAT level (< 11 µmol/L or < 57 mg/dL by nephelometry) AND SERPINA1 genotyping or isoelectric focusing (IEF)
  • PULMONARY ELIGIBILITY FOR AUGMENTATION: FEV1 15–65% predicted on spirometry; CT-documented emphysema (quantitative PD15 densitometry); non-smoker or smoking cessation confirmed ≥ 6 months; absence of IgA deficiency (risk of anaphylaxis to plasma products)
  • LIVER DISEASE EVALUATION: All AATD patients require baseline liver assessment — serum LFTs, FibroScan® (liver stiffness ≥ 7 kPa warrants enhanced surveillance), abdominal ultrasound, and AFP for HCC screening in cirrhotic patients
  • REQUIRED PRE-TREATMENT DIAGNOSTICS: Full pulmonary function tests (spirometry, body plethysmography, DLCO); HRCT thorax with quantitative densitometry; 6-minute walk test (6MWT) and SGRQ-C quality-of-life score; echocardiography (ECHO) to exclude pulmonary hypertension (RVSP > 40 mmHg modifies transplant candidacy); complete blood count, coagulation profile, serum protein electrophoresis; hepatitis B/C serology and HIV screening
  • +4 more

Treatment Options & Approaches

  • STANDARD AAT AUGMENTATION THERAPY (INTRAVENOUS): Weekly IV infusion of purified, pasteurised, human plasma-derived alpha-1-antitrypsin concentrate at 60 mg/kg body weight, administered over 15–30 minutes in an outpatient or day-care setting.
  • This is the only FDA-approved, EMA-approved disease-modifying therapy for AATD-related emphysema.
  • The RAPID and RAPID-OLE trials (the only double-blind, placebo-controlled studies in AATD) demonstrated a 34% reduction in annual CT lung density loss (PD15 endpoint) and a significant benefit in FEV1 decline in the treatment arm over 4 years.

Recovery

  • PHASE 1 — PRE-ARRIVAL PREPARATION (2–4 weeks before travel):

Risks to be aware of

  • AAT augmentation therapy has an established safety profile across three decades of clinical use, but patients and clinicians must consider the following specific risks and limitations:
Full details →

Why GAF Healthcare

  • GAF Healthcare provides a fully integrated non-medical support infrastructure designed to eliminate barriers to international treatment access for AATD patients:

Common questions about Alpha-1-Antitrypsin Deficiency

What is the cost of Alpha-1-Antitrypsin Deficiency Treatment (AAT Augmentation Therapy) in India versus the UAE?
An initial international treatment visit to India — covering comprehensive AATD diagnostic confirmation (spirometry, quantitative HRCT, FibroScan®, SERPINA1 genotyping, full blood panel), MDT consultations, and initiation of AAT augmentation therapy (2 supervised infusions) — costs approximately USD 2,500 to USD 6,000 at JCI- and NABH-accredited hospitals in Mumbai, Delhi, or Chennai. Equivalent treatment at JCI- and DHA-accredited hospitals in Dubai or Abu Dhabi typically ranges from USD 5,000 to USD 12,000 for the same scope of care. This represents a cost saving of 40–60% in India versus the UAE. It is important to note that AAT augmentation therapy is a lifelong weekly infusion; the cost of ongoing therapy once the patient returns home depends on local pharmaceutical pricing and insurance coverage. For surgical interventions — endobronchial valve lung volume reduction (approximately USD 8,000–15,000 in India vs. USD 18,000–30,000 in UAE) or bilateral lung transplantation (approximately USD 40,000–75,000 in India vs. USD 120,000–200,000 in UAE) — GAF Healthcare provides itemised cost estimates following clinical evaluation. All quoted ranges are inclusive of hospital stay, standard medications, nursing care, and standard investigative procedures.
How long do I need to stay in India or the UAE before I am fit to fly home after starting AAT Augmentation Therapy?
For patients travelling internationally to initiate AAT augmentation therapy, the recommended minimum in-country stay is 10 to 14 days. The first 3 days are dedicated to comprehensive baseline diagnostics and MDT review. Therapy is initiated on Day 4 with the first IV infusion, followed by a second infusion approximately 7 days later. A minimum 60-minute post-infusion observation period is required after each infusion to monitor for hypersensitivity reactions. Flight clearance is issued by the treating pulmonologist once two infusions have been tolerated without adverse events, the patient's SpO2 is ≥ 92% on room air at rest, and no acute pulmonary exacerbation is occurring. Patients with baseline resting SpO2 below 92% must undergo a hypoxia altitude simulation test (HAST) to determine whether in-flight supplemental oxygen (typically 2 L/min via nasal cannula) is required — this adds 1–2 days to the pre-departure timeline. For patients undergoing endobronchial valve (BLVR) procedures, the in-country stay is typically 7–10 days post-procedure given the 10–14% pneumothorax risk in the first 72 hours. Lung or liver transplant recipients require a minimum 4–8 weeks in-country post-surgery before international travel clearance.
What is the success rate of AAT Augmentation Therapy and related AATD treatments?
Success rates vary by treatment modality and the outcome measure used. For AAT augmentation therapy, the landmark RAPID and RAPID-OLE double-blind placebo-controlled trials demonstrated a 34% reduction in annual CT lung density loss (PD15 endpoint) compared to placebo over 2–4 years — the most objective and validated measure of disease-modifying efficacy in AATD emphysema. Augmentation therapy stabilises lung function trajectory in approximately 70–85% of compliant patients, with the greatest benefit seen in those with FEV1 between 35–65% predicted. The therapy does not reverse existing emphysema but significantly slows progression. For endobronchial lung volume reduction (Zephyr valves), the LIBERATE trial demonstrated a mean FEV1 improvement of 14.6% above placebo at 12 months, with 47% of treated patients achieving a clinically meaningful response (MCID ≥ 15% FEV1 improvement). For bilateral lung transplantation in AATD, the ISHLT registry reports 1-year survival of 80–85% and 5-year survival of 50–60%, which is among the better outcomes of all COPD indications for transplant. Liver transplantation for AATD-related cirrhosis achieves 1-year graft survival of 85–90% at high-volume centres in India. Emerging RNA interference therapies (fazirsiran) have shown 80–90% reduction in hepatic Z-AAT polymer in Phase 2 trials, with liver fibrosis stabilisation or improvement in the majority of participants. GAF Healthcare partner centres in India and the UAE report outcomes consistent with or superior to published international benchmarks, supported by prospective outcome tracking and participation in the Alpha-1 International Registry (AIR).

How GAF Healthcare Assists in Choosing the Best Hospital for Alpha-1-Antitrypsin Deficiency in Bengaluru, India

Discover the Top Hospitals for Alpha-1-Antitrypsin Deficiency in Bengaluru, India

This page lists 10 accredited liver transplant & hpb hospitals in Bengaluru, India, so you can compare accreditation, specialties and bed capacity in one place.

Support When You Need It Most

Share your medical reports with us on WhatsApp or email. Our medical team reviews them and comes back with a recommended hospital and treatment plan for your case.

Transparent, All-Inclusive Costs

We provide a single, itemised quote covering hospital charges and stay — no hidden fees, and there's no charge for requesting an estimate. Use our cost calculator alongside this page for a first estimate.

Visa, Travel and Stay Coordination

Once you choose a hospital, we help arrange the medical visa invitation letter, hotel or serviced-apartment booking nearby, airport pickup and transport to your appointments.

Curious what treatment might cost for your case? Use our cost calculator for a personalized estimate.

Patient Success Story

Iraqi Family's Journey: Baby Ibrahim's Life-Saving Heart Surgery in India
Common Questions

Frequently asked questions about alpha-1-antitrypsin deficiency in Bengaluru, India

How many liver transplant & hpb hospitals are listed in Bengaluru, India?
10 hospitals in our Bengaluru, India directory are currently listed for liver transplant & hpb including Alpha-1-Antitrypsin Deficiency.
How do you choose which hospitals to list?
A hospital appears on this page when Liver Transplant & HPB is among its listed specialties and it is located in Bengaluru, India. Hospitals are not ranked by a proprietary "best" score — the order follows the listed rating (highest first), the same field shown on each hospital's profile.
How much does treatment cost in India?
Cost varies by hospital, city and individual case. Use our cost calculator for a personalized estimate — see the link on this page.
Are there liver transplant & hpb hospitals for this in other India cities?
See the "Hospitals in other cities" links on this page for the full India list.
Are these hospitals internationally accredited?
Hospitals listed on this page carry accreditations including NABH, JCI, NABL, ISO 9001 — see the accreditation badge shown for each hospital below.
Can I get a treatment plan and cost estimate before I travel?
Yes. Share your medical reports with the GAF Healthcare team over WhatsApp or email, and our medical team will review them and come back with a recommended hospital, a treatment plan and an itemised cost estimate before you commit to anything.
Do you help with visa, travel and accommodation?
Yes. Once you choose a hospital, our team helps arrange the medical visa invitation letter, book accommodation near the hospital, and organise airport pickup and transport to appointments.
What support do I get during and after treatment?
Our medical team reviews your reports and stays in touch throughout your treatment journey — from the first consultation through recovery, including after you return home.
What does the "Featured" label next to a hospital's name mean?
"Featured" reflects editorial prominence on this listing, not a clinical ranking or a claim that it is the "best" hospital.
How do I get matched with the right hospital for alpha-1-antitrypsin deficiency?
Share your medical reports and requirements with the GAF Healthcare team, and our medical coordinators will recommend a suitable hospital from this list based on your case.
Does the listed cost cover everything?
The figures shown are an indicative planning estimate, not a final quote from a specific hospital. Our team provides a single, itemised, all-inclusive quote before you make any commitment.
🤔

Still have questions?

Our coordinators are here to answer your questions about alpha-1-antitrypsin deficiency in Bengaluru, India.

Next Step

Share your medical reports with us and our team will recommend a hospital and treatment plan for alpha-1-antitrypsin deficiency in Bengaluru, India.

Contact us to report an inaccuracy on this page.